{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:25:50Z","timestamp":1792661150441,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ophtha.2008.06.009","type":"journal-article","created":{"date-parts":[[2008,8,10]],"date-time":"2008-08-10T04:09:50Z","timestamp":1218341390000},"page":"2141-2145.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Evaluation of Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy"],"prefix":"10.1016","volume":"115","clinical-trial-number":[{"clinical-trial-number":"nct00468429","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dilraj S.","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satinder Pal Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2008.06.009_bib1","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1167\/iovs.07-0878","article-title":"Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery","volume":"48","author":"Honjo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.06.009_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archopht.1983.01040010795021","article-title":"Histologic characteristics of filtering blebs in glaucomatous eyes","volume":"101","author":"Addicks","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib3","first-page":"84","article-title":"Clinico pathological correlation in eyes with failed fistulizing surgery","volume":"103","author":"Hitchings","year":"1983","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.ophtha.2008.06.009_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/eye.1994.44","article-title":"Activation and suppression of fibroblast function","volume":"8","author":"Khaw","year":"1994","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2008.06.009_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ophtha.2006.01.062","article-title":"Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma","volume":"113","author":"Fontana","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.06.009_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1442-9071.2001.00437.x","article-title":"The efficacy and safety of intraoperative and\/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy","volume":"29","author":"Singh","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0039-6257(03)00038-9","article-title":"Antifibrotics and wound healing in glaucoma surgery","volume":"48","author":"Lama","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(14)74481-2","article-title":"Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil","volume":"114","author":"Stamper","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib9","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A phase III study of subconjunctival human anti-transforming growth factor beta (2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.06.009_bib10","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1167\/iovs.02-0978","article-title":"Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery","volume":"44","author":"Mead","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.06.009_bib11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1167\/iovs.03-1351","article-title":"Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery","volume":"45","author":"Eibl","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.06.009_bib12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1167\/iovs.05-0361","article-title":"p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts","volume":"47","author":"Meyer-ter-Vehn","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.06.009_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00061198-200412000-00005","article-title":"A pilot study of a system for grading of drainage blebs after glaucoma surgery","volume":"13","author":"Wells","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2008.06.009_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bjo.2003.020016","article-title":"Defining \u201coccludable\u201d angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people","volume":"88","author":"Foster","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/1542-8877-20060301-11","article-title":"Intravitreal bevacizumab in a patient with neovascular glaucoma","volume":"37","author":"Kahook","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ophtha.2008.06.009_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2007.0036","article-title":"Role of intravitreal bevacizumab in neovascular glaucoma","volume":"23","author":"Gheith","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2008.06.009_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma","volume":"16","author":"Yazdani","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2008.06.009_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099248","article-title":"Intravitreal bevacizumab for filtering surgery","volume":"39","author":"Jonas","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ophtha.2008.06.009_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00055735-200104000-00011","article-title":"Modulation of wound healing after glaucoma surgery","volume":"12","author":"Khaw","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib20","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.06.009_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2008.06.009_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.gt.3302162","article-title":"Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis","volume":"11","author":"Jacobi","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.ophtha.2008.06.009_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3928\/1542-8877-20060301-12","article-title":"Needle bleb revision of encapsulated filtering bleb with bevacizumab","volume":"37","author":"Kahook","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ophtha.2008.06.009_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archopht.1988.01060130095036","article-title":"Cellular proliferation after experimental glaucoma filtration surgery","volume":"106","author":"Jampel","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00941765","article-title":"Effects of mitomycin C on expression of proliferating cell nuclear antigen after filtering surgery in rabbits","volume":"35","author":"Watanabe","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/exer.1994.1037","article-title":"Modulation of human fibroblast activity by selected angiogenesis inhibitors","volume":"58","author":"Wong","year":"1994","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2008.06.009_bib27","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1242\/jcs.02483","article-title":"VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling","volume":"118","author":"Kano","year":"2005","journal-title":"J Cell Sci"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.06.009_bib28","doi-asserted-by":"crossref","first-page":"II365","DOI":"10.1161\/01.CIR.92.9.365","article-title":"Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo","volume":"92","author":"Asahara","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2008.06.009_bib29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","article-title":"Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis","volume":"141","author":"Seghezzi","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archsurg.134.2.200","article-title":"Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing","volume":"134","author":"Corral","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ophtha.2008.06.009_bib31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.iae.0000233327.68433.02","article-title":"Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients","volume":"26","author":"Beer","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2008.06.009_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.06.009_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis","volume":"142","author":"Grisanti","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/112067210801800214","article-title":"Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma","volume":"18","author":"Chalam","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.06.009_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0161-6420(97)30347-9","article-title":"Intermediate-term outcome of variable dose mitomycin C filtering surgery","volume":"104","author":"Cheung","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.06.009_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00061198-199808000-00003","article-title":"Trabeculectomy with mitomycin C: intermediate-term results","volume":"7","author":"Perkins","year":"1998","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2008.06.009_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000112623","article-title":"Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up","volume":"222","author":"Cillino","year":"2008","journal-title":"Ophthalmologica"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008005599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642008005599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:55:35Z","timestamp":1758981335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642008005599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0161642008005599"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.06.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10444956.11276054","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}